Blood-brain barrier and innate immunity in the pathogenesis of Alzheimer's disease.

[1]  Alzheimer's Disease Neuroimaging Initiative.  A blood-based signature of cerebrospinal fluid Aβ 1–42 status , 2019 .

[2]  Nicola Thrupp,et al.  The Major Risk Factors for Alzheimer’s Disease: Age, Sex, and Genes Modulate the Microglia Response to Aβ Plaques , 2019, Cell reports.

[3]  Sara Linse,et al.  Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer’s disease , 2019, Acta Neuropathologica.

[4]  P. Reddy,et al.  Small molecules as therapeutic drugs for Alzheimer's disease , 2019, Molecular and Cellular Neuroscience.

[5]  Silvia Maioli,et al.  Alterations in cholesterol metabolism as a risk factor for developing Alzheimer’s disease: Potential novel targets for treatment , 2019, The Journal of Steroid Biochemistry and Molecular Biology.

[6]  Genetic,et al.  Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing , 2019, Nature Genetics.

[7]  L. Mucke,et al.  Fibrinogen Induces Microglia-Mediated Spine Elimination and Cognitive Impairment in an Alzheimer’s Disease Model , 2019, Neuron.

[8]  Ulrich Sure,et al.  Edinburgh Research Explorer Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution , 2022 .

[9]  Bradley T. Hyman,et al.  Beyond the neuron–cellular interactions early in Alzheimer disease pathogenesis , 2019, Nature Reviews Neuroscience.

[10]  Evan Z. Macosko,et al.  Single‐Cell RNA Sequencing of Microglia throughout the Mouse Lifespan and in the Injured Brain Reveals Complex Cell‐State Changes , 2019, Immunity.

[11]  Laura M Parkes,et al.  Water-exchange MRI detects subtle blood-brain barrier breakdown in Alzheimer's disease rats , 2019, NeuroImage.

[12]  S. Sensi,et al.  Copper and Zinc Dysregulation in Alzheimer's Disease. , 2018, Trends in pharmacological sciences.

[13]  Gwendolyn E. Kaeser,et al.  Somatic APP gene recombination in Alzheimer’s disease and normal neurons , 2018, Nature.

[14]  B. Winblad,et al.  Autophagy-lysosomal defect in human CADASIL vascular smooth muscle cells. , 2018, European journal of cell biology.

[15]  B. Fiebich,et al.  Role of Microglia TLRs in Neurodegeneration , 2018, Front. Cell. Neurosci..

[16]  Y. Ge,et al.  Measurement of blood‐brain barrier permeability using dynamic contrast‐enhanced magnetic resonance imaging with reduced scan time , 2018, Magnetic resonance in medicine.

[17]  M. Colonna,et al.  The identity and function of microglia in neurodegeneration , 2018, Nature Immunology.

[18]  H. Weiner,et al.  Microglial signatures and their role in health and disease , 2018, Nature Reviews Neuroscience.

[19]  John Hardy,et al.  Selective vulnerability in neurodegenerative diseases , 2018, Nature Neuroscience.

[20]  Mark T. W. Ebbert,et al.  Microglial translational profiling reveals a convergent APOE pathway from aging, amyloid, and tau , 2018, The Journal of experimental medicine.

[21]  Rudolph E. Tanzi,et al.  Alzheimer’s Disease-Associated β-Amyloid Is Rapidly Seeded by Herpesviridae to Protect against Brain Infection , 2018, Neuron.

[22]  Nathan D. Price,et al.  Summary of the 11th International Conference on Human Herpesviruses‐6A, ‐6B, and ‐7 , 2018, Neuron.

[23]  I. Alafuzoff,et al.  Rapid amyloid‐β oligomer and protofibril accumulation in traumatic brain injury , 2018, Brain pathology.

[24]  Jie Zheng,et al.  Design of nonapeptide LVFFARKHH: A bifunctional agent against Cu2+‐mediated amyloid β‐protein aggregation and cytotoxicity , 2018, Journal of molecular recognition : JMR.

[25]  M. Tabaton,et al.  A silver lining for 24-hydroxycholesterol in Alzheimer's disease: The involvement of the neuroprotective enzyme sirtuin 1 , 2018, Redox biology.

[26]  L. Piccio,et al.  The Microglial Innate Immune Receptor TREM2 Is Required for Synapse Elimination and Normal Brain Connectivity , 2018, Immunity.

[27]  Maya L. Gosztyla,et al.  The Physiological Roles of Amyloid-β Peptide Hint at New Ways to Treat Alzheimer's Disease , 2018, Front. Aging Neurosci..

[28]  K. Lenz,et al.  Microglia and Beyond: Innate Immune Cells As Regulators of Brain Development and Behavioral Function , 2018, Front. Immunol..

[29]  L. Sevenich.  Brain-Resident Microglia and Blood-Borne Macrophages Orchestrate Central Nervous System Inflammation in Neurodegenerative Disorders and Brain Cancer , 2018, Front. Immunol..

[30]  J. Ryu,et al.  Fibrinogen in neurological diseases: mechanisms, imaging and therapeutics , 2018, Nature Reviews Neuroscience.

[31]  Tuan Leng Tay,et al.  Histone Deacetylases 1 and 2 Regulate Microglia Function during Development, Homeostasis, and Neurodegeneration in a Context‐Dependent Manner , 2018, Immunity.

[32]  M. Ansari,et al.  Inhibiting Effect of Zinc Oxide Nanoparticles on Advanced Glycation Products and Oxidative Modifications: a Potential Tool to Counteract Oxidative Stress in Neurodegenerative Diseases , 2018, Molecular Neurobiology.

[33]  K. Plate,et al.  Functional morphology of the blood-brain barrier in health and disease , 2018, Acta Neuropathologica.

[34]  Luc Buée,et al.  Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies? , 2018, Biomedical journal.

[35]  Berislav V. Zlokovic,et al.  Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders , 2018, Nature Reviews Neurology.

[36]  G. Guerra,et al.  Complexity and Selectivity of γ-Secretase Cleavage on Multiple Substrates: Consequences in Alzheimer's Disease and Cancer. , 2017, Journal of Alzheimer's disease : JAD.

[37]  A. Huber,et al.  An emerging role for eotaxins in neurodegenerative disease. , 2016, Clinical immunology.

[38]  E. V. van Dijk,et al.  Plasma A&bgr; (Amyloid-&bgr;) Levels and Severity and Progression of Small Vessel Disease , 2018, Stroke.

[39]  Maya L. Gosztyla,et al.  Alzheimer's Amyloid-β is an Antimicrobial Peptide: A Review of the Evidence. , 2018, Journal of Alzheimer's disease : JAD.

[40]  W. M. van der Flier,et al.  Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease , 2018, Alzheimer's Research & Therapy.

[41]  Yue-Ming Li,et al.  The role of astrocytes in amyloid production and Alzheimer's disease , 2017, Open Biology.

[42]  H. Al‐Salami,et al.  Blood-Brain Barrier Dysfunction Precedes Cognitive Decline and Neurodegeneration in Diabetic Insulin Resistant Mouse Model: An Implication for Causal Link , 2017, Front. Aging Neurosci..

[43]  B. Zlokovic,et al.  Alzheimer’s disease: A matter of blood–brain barrier dysfunction? , 2017, The Journal of experimental medicine.

[44]  Gabriela Constantin,et al.  The blood-brain barrier in Alzheimer's disease , 2017, Neurobiology of Disease.

[45]  Xiaobao Zhang,et al.  Triggering Receptor Expressed on Myeloid Cells 2 Overexpression Inhibits Proinflammatory Cytokines in Lipopolysaccharide-Stimulated Microglia , 2017, Mediators of inflammation.

[46]  R. Ransohoff,et al.  TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy , 2017, Molecular Neurodegeneration.

[47]  D. Holtzman,et al.  TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy , 2017, Proceedings of the National Academy of Sciences.

[48]  Markus Glatzel,et al.  The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases. , 2017, Immunity.

[49]  TREM2 promotes Aβ phagocytosis by upregulating C/EBPα-dependent CD36 expression in microglia , 2017, Scientific Reports.

[50]  T. Kanekiyo,et al.  Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer’s Disease , 2017, International journal of molecular sciences.

[51]  K. Schuurman,et al.  Staining of HLA-DR, Iba1 and CD68 in human microglia reveals partially overlapping expression depending on cellular morphology and pathology , 2017, Journal of Neuroimmunology.

[52]  L. Cucullo,et al.  Proximate Mediators of Microvascular Dysfunction at the Blood-Brain Barrier: Neuroinflammatory Pathways to Neurodegeneration , 2017, BioMed research international.

[53]  M. van Buchem,et al.  Subtle blood‐brain barrier leakage rate and spatial extent: Considerations for dynamic contrast‐enhanced MRI , 2017, Medical physics.

[54]  B. Zlokovic,et al.  Role of clusterin in the brain vascular clearance of amyloid-β , 2017, Proceedings of the National Academy of Sciences.

[55]  J. Budni,et al.  Minocycline reduces inflammatory parameters in the brain structures and serum and reverses memory impairment caused by the administration of amyloid β (1-42) in mice , 2017, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[56]  I. Amit,et al.  A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease , 2017, Cell.

[57]  David V. Hansen,et al.  TREM2, Microglia, and Neurodegenerative Diseases. , 2017, Trends in molecular medicine.

[58]  Anastasia G. Efthymiou,et al.  Late onset Alzheimer’s disease genetics implicates microglial pathways in disease risk , 2017, Molecular Neurodegeneration.

[59]  Pu Wang,et al.  Metal ions influx is a double edged sword for the pathogenesis of Alzheimer’s disease , 2017, Ageing Research Reviews.

[60]  P. Hof,et al.  Monoaminergic neuropathology in Alzheimer’s disease , 2017, Progress in Neurobiology.

[61]  S. Emadi,et al.  Effect of metal chelators on the aggregation of beta-amyloid peptides in the presence of copper and iron , 2017, BioMetals.

[62]  M. Fornage,et al.  Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association , 2017, Circulation.

[63]  L. Fratiglioni,et al.  Mixed brain lesions mediate the association between cardiovascular risk burden and cognitive decline in old age: A population-based study , 2017, Alzheimer's & Dementia.

[64]  R. Burnett,et al.  Living near major roads and the incidence of dementia, Parkinson's disease, and multiple sclerosis: a population-based cohort study , 2017, The Lancet.

[65]  R. Simó,et al.  Cognitive impairment and dementia: a new emerging complication of type 2 diabetes—The diabetologist’s perspective , 2017, Acta Diabetologica.

[66]  Jie Chen,et al.  Pathological concentration of zinc dramatically accelerates abnormal aggregation of full-length human Tau and thereby significantly increases Tau toxicity in neuronal cells. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[67]  B. Engelhardt,et al.  The movers and shapers in immune privilege of the CNS , 2017, Nature Immunology.

[68]  Manoj Kumar,et al.  INGE GRUNDKE-IQBAL AWARD FOR ALZHEIMER’S RESEARCH: NEUROTOXIC REACTIVE ASTROCYTES ARE INDUCED BY ACTIVATED MICROGLIA , 2019, Alzheimer's & Dementia.

[69]  Deborah A. Levine,et al.  Post-stroke dementia – a comprehensive review , 2017, BMC Medicine.

[70]  HHV-6A in vitro infection of thyrocytes and T cells alters the expression of miRNA associated to autoimmune thyroiditis , 2017, Virology Journal.

[71]  Yigong Shi,et al.  Analysis of 138 pathogenic mutations in presenilin-1 on the in vitro production of Aβ42 and Aβ40 peptides by γ-secretase , 2016, Proceedings of the National Academy of Sciences.

[72]  J. Crary.  Primary age-related tauopathy and the amyloid cascade hypothesis: the exception that proves the rule? , 2016, Journal of neurology & neuromedicine.

[73]  S. Studenski,et al.  Basal body temperature as a biomarker of healthy aging , 2016, AGE.

[74]  Jyrki Lötjönen,et al.  Multimodal analysis to predict shunt surgery outcome of 284 patients with suspected idiopathic normal pressure hydrocephalus , 2016, Acta Neurochirurgica.

[75]  Walter H. Backes,et al.  Neurovascular unit impairment in early Alzheimer's disease measured with magnetic resonance imaging , 2016, Neurobiology of Aging.

[76]  Yanjie Guo,et al.  CX3CL1/CX3CR1 in Alzheimer's Disease: A Target for Neuroprotection , 2016, BioMed research international.

[77]  B. Zlokovic,et al.  Pericytes of the neurovascular unit: key functions and signaling pathways , 2016, Nature Neuroscience.

[78]  R. Tanzi,et al.  Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer’s disease , 2016, Science Translational Medicine.

[79]  Rufus Akinyemi,et al.  Stroke injury, cognitive impairment and vascular dementia , 2016, Biochimica et biophysica acta.

[80]  Xiong Jiang,et al.  An individual with human immunodeficiency virus, dementia, and central nervous system amyloid deposition , 2016, Alzheimer's & dementia.

[81]  A. Krassioukov,et al.  Neurovascular coupling in humans: Physiology, methodological advances and clinical implications , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[82]  Arthur W. Toga,et al.  Brain imaging of neurovascular dysfunction in Alzheimer’s disease , 2016, Acta Neuropathologica.

[83]  R. Nitsch,et al.  Tau pathology-dependent remodelling of cerebral arteries precedes Alzheimer’s disease-related microvascular cerebral amyloid angiopathy , 2016, Acta Neuropathologica.

[84]  Eric Karran,et al.  The Cellular Phase of Alzheimer’s Disease , 2016, Cell.

[85]  J. Jane,et al.  Concurrent Alzheimer's pathology in patients with clinical normal pressure hydrocephalus: correlation of high-volume lumbar puncture results, cortical brain biopsies, and outcomes. , 2016, Journal of neurosurgery.

[86]  T. Morgan,et al.  The APOE4 allele shows opposite sex bias in microbleeds and Alzheimer's disease of humans and mice , 2016, Neurobiology of Aging.

[87]  P. Hof,et al.  Tau Protein Hyperphosphorylation and Aggregation in Alzheimer’s Disease and Other Tauopathies, and Possible Neuroprotective Strategies , 2016, Biomolecules.

[88]  B. Zlokovic,et al.  Accelerated pericyte degeneration and blood–brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer’s disease , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[89]  T. Bayer,et al.  Endothelial LRP1 transports amyloid-β(1-42) across the blood-brain barrier. , 2015, The Journal of clinical investigation.

[90]  G. Eslick,et al.  Pharmacological Agents Targeting γ-Secretase Increase Risk of Cancer and Cognitive Decline in Alzheimer's Disease Patients: A Systematic Review and Meta-Analysis. , 2016, Journal of Alzheimer's disease : JAD.

[91]  Brian J. Bacskai,et al.  Lymphatic Clearance of the Brain: Perivascular, Paravascular and Significance for Neurodegenerative Diseases , 2016, Cellular and Molecular Neurobiology.

[92]  Zhen Zhao,et al.  Establishment and Dysfunction of the Blood-Brain Barrier , 2015, Cell.

[93]  Jennifer Luebke,et al.  Depletion of microglia and inhibition of exosome synthesis halt tau propagation , 2015, Nature Neuroscience.

[94]  D. Holtzman,et al.  Re-evaluation of the Blood-Brain Barrier in the Presence of Alzheimer’s Disease Pathology , 2015, Neuron.

[95]  M. Brug,et al.  Lack of Widespread BBB Disruption in Alzheimer’s Disease Models: Focus on Therapeutic Antibodies , 2015, Neuron.

[96]  R. Vandenbroucke,et al.  Friends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative Diseases , 2015, Mediators of inflammation.

[97]  Shengyuan Liu,et al.  The nitric oxide synthase 3 G894T polymorphism associated with Alzheimer’s disease risk: a meta-analysis , 2015, Scientific Reports.

[98]  D. Catalucci,et al.  Neutrophils promote Alzheimer's disease–like pathology and cognitive decline via LFA-1 integrin , 2015, Nature Medicine.

[99]  Christina M. Weaver,et al.  Age-related changes to layer 3 pyramidal cells in the rhesus monkey visual cortex. , 2015, Cerebral cortex.

[100]  Timothy J Keyes,et al.  Structural and functional features of central nervous system lymphatics , 2015, Nature.

[101]  Britta Engelhardt,et al.  Brain barriers: Crosstalk between complex tight junctions and adherens junctions , 2015, The Journal of cell biology.

[102]  Adila Elobeid,et al.  Correlations Between Mini-Mental State Examination Score, Cerebrospinal Fluid Biomarkers, and Pathology Observed in Brain Biopsies of Patients With Normal-Pressure Hydrocephalus , 2015, Journal of neuropathology and experimental neurology.

[103]  F. Ginhoux,et al.  C-Myb(+) erythro-myeloid progenitor-derived fetal monocytes give rise to adult tissue-resident macrophages. , 2015, Immunity.

[104]  Jesse D. Sengillo,et al.  GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration , 2015, Nature Neuroscience.

[105]  Y. Youn,et al.  Cerebrospinal Fluid β-Amyloid1–42 Levels in the Differential Diagnosis of Alzheimer’s Disease—Systematic Review and Meta-Analysis , 2015, PloS one.

[106]  F. Edwards,et al.  A genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology. , 2015, Cell reports.

[107]  W. Le,et al.  Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases , 2015, Molecular Neurobiology.

[108]  C. Nicholson,et al.  Clearance systems in the brain-implications for Alzheimer disease. , 2015, Nature reviews. Neurology.

[109]  Thomas Wisniewski,et al.  Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy , 2015, Acta Neuropathologica.

[110]  R. Daneman,et al.  The blood-brain barrier. , 2015, Cold Spring Harbor perspectives in biology.

[111]  Y. Nakagawa,et al.  Role of Microglial M1/M2 Polarization in Relapse and Remission of Psychiatric Disorders and Diseases , 2014, Pharmaceuticals.

[112]  K. Jellinger,et al.  The overlap between vascular disease and Alzheimer’s disease - lessons from pathology , 2014, BMC Medicine.

[113]  Janna H. Neltner,et al.  Primary age-related tauopathy (PART): a common pathology associated with human aging , 2014, Acta Neuropathologica.

[114]  T. Nakada,et al.  Water influx into cerebrospinal fluid is significantly reduced in senile plaque bearing transgenic mice, supporting beta-amyloid clearance hypothesis of Alzheimer’s disease , 2014, Neurological research.

[115]  B. Vissel,et al.  Inconsistencies and Controversies Surrounding the Amyloid Hypothesis of Alzheimer's Disease , 2014, Acta neuropathologica communications.

[116]  Leah P. Dickstein,et al.  Is Peripheral Immunity Regulated by Blood-Brain Barrier Permeability Changes? , 2014, PloS one.

[117]  J. Molinuevo,et al.  TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis , 2014, Science Translational Medicine.

[118]  K. Eikermann-Haerter.  Spreading Depolarization May Link Migraine and Stroke , 2014, Headache.

[119]  P. Hof,et al.  Early Failure of the Default‐Mode Network and the Pathogenesis of Alzheimer's Disease , 2014, CNS neuroscience & therapeutics.

[120]  M. Vernooij,et al.  Cerebral microbleeds: Spatial distribution implications , 2014 .

[121]  P. Faller,et al.  Metal ions and intrinsically disordered proteins and peptides: from Cu/Zn amyloid-β to general principles. , 2014, Accounts of chemical research.

[122]  P. Saftig,et al.  Regulated Proteolysis of NOTCH2 and NOTCH3 Receptors by ADAM10 and Presenilins , 2014, Molecular and Cellular Biology.

[123]  T. Ikezu,et al.  Tau-tubulin kinase , 2014, Front. Mol. Neurosci..

[124]  S. Hickman,et al.  TREM2 and the neuroimmunology of Alzheimer's disease. , 2014, Biochemical pharmacology.

[125]  J. Morley,et al.  The role of amyloid-beta in the regulation of memory. , 2014, Biochemical pharmacology.

[126]  Z. Katušić,et al.  Endothelial nitric oxide: protector of a healthy mind. , 2014, European heart journal.

[127]  A. Hofman,et al.  Apolipoprotein E genotype influences spatial distribution of cerebral microbleeds , 2014, Neurobiology of Aging.

[128]  Andre Altmann,et al.  Sex modifies the APOE‐related risk of developing Alzheimer disease , 2014, Annals of neurology.

[129]  Libin Cui,et al.  Accelerated neurodegeneration and neuroinflammation in transgenic mice expressing P301L tau mutant and tau-tubulin kinase 1. , 2014, The American journal of pathology.

[130]  W. Le,et al.  Jmjd3 is essential for the epigenetic modulation of microglia phenotypes in the immune pathogenesis of Parkinson’s disease , 2013, Cell Death and Differentiation.

[131]  Timothy H. Rumbell,et al.  Functional consequences of age-related morphologic changes to pyramidal neurons of the rhesus monkey prefrontal cortex , 2013, Journal of Computational Neuroscience.

[132]  J. Jurčovičová,et al.  Glucose transport in brain - effect of inflammation. , 2014, Endocrine regulations.

[133]  B. Zlokovic,et al.  Pericyte loss influences Alzheimer-like neurodegeneration in mice , 2013, Nature Communications.

[134]  S. Trouche,et al.  Amyloid beta immunization worsens iron deposits in the choroid plexus and cerebral microbleeds , 2013, Neurobiology of Aging.

[135]  Beth Stevens,et al.  TGF-β Signaling Regulates Neuronal C1q Expression and Developmental Synaptic Refinement , 2013, Nature Neuroscience.

[136]  Daniel J. R. Christensen,et al.  Sleep Drives Metabolite Clearance from the Adult Brain , 2013, Science.

[137]  P. Hof,et al.  Pathogenesis, modulation, and therapy of Alzheimer’s disease: A perspective on roles of liver-X receptors , 2013 .

[138]  Jie-zhong Yu,et al.  Rho Kinase Inhibitor Fasudil Regulates Microglia Polarization and Function , 2013, Neuroimmunomodulation.

[139]  Philip S. Insel,et al.  CSF protein biomarkers predicting longitudinal reduction of CSF β-amyloid42 in cognitively healthy elders , 2013, Translational Psychiatry.

[140]  H. Braak,et al.  Amyloid-β may be released from non-junctional varicosities of axons generated from abnormal tau-containing brainstem nuclei in sporadic Alzheimer’s disease: a hypothesis , 2013, Acta Neuropathologica.

[141]  C. Combs,et al.  Expression and function of APP and its metabolites outside the central nervous system , 2013, Experimental Gerontology.

[142]  A. Paetau,et al.  Amyloid precursor protein (APP) A673T mutation in the elderly Finnish population , 2013, Neurobiology of Aging.

[143]  I. Sarkar,et al.  Origins of amyloid-β , 2013, BMC Genomics.

[144]  J. Nabekura,et al.  Microglia: actively surveying and shaping neuronal circuit structure and function , 2013, Trends in Neurosciences.

[145]  A Suzumura,et al.  Minocycline selectively inhibits M1 polarization of microglia , 2013, Cell Death and Disease.

[146]  M. Schwartz,et al.  Orchestrated leukocyte recruitment to immune-privileged sites: absolute barriers versus educational gates , 2013, Nature Reviews Immunology.

[147]  V. Perry,et al.  Review: Activation patterns of microglia and their identification in the human brain , 2013, Neuropathology and applied neurobiology.

[148]  A. Singleton,et al.  TREM2 variants in Alzheimer's disease. , 2013, The New England journal of medicine.

[149]  L. d’Uscio,et al.  Supplementation of nitric oxide attenuates AβPP and BACE1 protein in cerebral microcirculation of eNOS-deficient mice. , 2012, Journal of Alzheimer's disease : JAD.

[150]  Sunhee C. Lee,et al.  Insulin-like growth factor 1 and 2 (IGF1, IGF2) expression in human microglia: differential regulation by inflammatory mediators , 2013, Journal of Neuroinflammation.

[151]  A. Verkhratsky,et al.  Homeostatic function of astrocytes: Ca2+ and Na+ signalling , 2012, Translational neuroscience.

[152]  Patrick R Hof,et al.  Influence of Highly Distinctive Structural Properties on the Excitability of Pyramidal Neurons in Monkey Visual and Prefrontal Cortices , 2012, The Journal of Neuroscience.

[153]  B. Hyman,et al.  Soluble forms of tau are toxic in Alzheimer’s disease , 2012, Translational neuroscience.

[154]  G. E. Vates,et al.  A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β , 2012, Science Translational Medicine.

[155]  Ole A. Andreassen,et al.  A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline , 2012, Nature.

[156]  Berislav V. Zlokovic,et al.  Apolipoprotein E controls cerebrovascular integrity via cyclophilin A , 2012, Nature.

[157]  A. Singleton,et al.  Exome sequencing reveals an unexpected genetic cause of disease: NOTCH3 mutation in a Turkish family with Alzheimer's disease , 2012, Neurobiology of Aging.

[158]  Nathan T. Ross,et al.  A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease. , 2012, The Journal of clinical investigation.

[159]  R. Nussinov,et al.  Antimicrobial properties of amyloid peptides. , 2012, Molecular pharmaceutics.

[160]  D. Holtzman,et al.  Tau elevations in the brain extracellular space correlate with reduced amyloid-β levels and predict adverse clinical outcomes after severe traumatic brain injury. , 2012, Brain : a journal of neurology.

[161]  Richard D. Smith,et al.  The cerebrospinal fluid proteome in HIV infection: change associated with disease severity , 2012, Clinical Proteomics.

[162]  N. V. van Sorge,et al.  Defense at the border: the blood-brain barrier versus bacterial foreigners. , 2012, Future microbiology.

[163]  Who fans the flames of Alzheimer's disease brains? Misfolded tau on the crossroad of neurodegenerative and inflammatory pathways , 2012, Journal of Neuroinflammation.

[164]  Pierre J Magistretti,et al.  Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. , 2011, Cell metabolism.

[165]  B. Zlokovic.  Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders , 2011, Nature Reviews Neuroscience.

[166]  G. Natoli,et al.  Transcriptional regulation of macrophage polarization: enabling diversity with identity , 2011, Nature Reviews Immunology.

[167]  Hai-Li Zhu,et al.  Fibrillization of Human Tau Is Accelerated by Exposure to Lead via Interaction with His-330 and His-362 , 2011, PloS one.

[168]  J. Growdon,et al.  Reactive glia not only associates with plaques but also parallels tangles in Alzheimer's disease. , 2011, The American journal of pathology.

[169]  Clifford R. Jack,et al.  Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup , 2011, Alzheimer's & Dementia.

[170]  A. Palmeri,et al.  Endogenous amyloid‐β is necessary for hippocampal synaptic plasticity and memory , 2011, Annals of neurology.

[171]  T. Preuss.  The human brain: rewired and running hot , 2011, Annals of the New York Academy of Sciences.

[172]  G. Šimić,et al.  HSV1 in Alzheimer’s disease: Myth or reality? , 2011 .

[173]  Seemant Chaturvedi,et al.  Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2011, Stroke.

[174]  V. Calhoun,et al.  Default mode network connectivity in stable vs progressive mild cognitive impairment , 2011, Neurology.

[175]  D. Kovacs,et al.  The many substrates of presenilin/γ-secretase. , 2011, Journal of Alzheimer's disease : JAD.

[176]  J. Morris,et al.  Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease , 2010, Science.

[177]  A. V. Santhanam,et al.  Endothelial Nitric Oxide Modulates Expression and Processing of Amyloid Precursor Protein , 2010, Circulation research.

[178]  R. Ransohoff,et al.  Regulation of Tau Pathology by the Microglial Fractalkine Receptor , 2010, Neuron.

[179]  V. Mathura,et al.  Impaired Orthotopic Glioma Growth and Vascularization in Transgenic Mouse Models of Alzheimer's Disease , 2010, The Journal of Neuroscience.

[180]  Eng H. Lo,et al.  The Science of Stroke: Mechanisms in Search of Treatments , 2010, Neuron.

[181]  S. Gordon,et al.  Alternative activation of macrophages: mechanism and functions. , 2010, Immunity.

[182]  Peter Güntert,et al.  Structural investigation of the C-terminal catalytic fragment of presenilin 1 , 2010, Proceedings of the National Academy of Sciences.

[183]  D. Head,et al.  Amyloid Plaques Disrupt Resting State Default Mode Network Connectivity in Cognitively Normal Elderly , 2010, Biological Psychiatry.

[184]  B. Hyman,et al.  The Alzheimer's Disease-Associated Amyloid β-Protein Is an Antimicrobial Peptide , 2010, PloS one.

[185]  David J. Begley,et al.  Structure and function of the blood–brain barrier , 2010, Neurobiology of Disease.

[186]  M. D'Andrea,et al.  Morphologically distinct types of amyloid plaques point the way to a better understanding of Alzheimer’s disease pathogenesis , 2010, Biotechnic & histochemistry : official publication of the Biological Stain Commission.

[187]  Keith A. Johnson,et al.  Disruption of Functional Connectivity in Clinically Normal Older Adults Harboring Amyloid Burden , 2009, The Journal of Neuroscience.

[188]  W. Banks,et al.  A Physiological Role for Amyloid-β Protein: Enhancement of Learning and Memory , 2010 .

[189]  F. LaFerla,et al.  Alzheimer's disease. , 2010, The New England journal of medicine.

[190]  Sergio Grinstein,et al.  Sensors and regulators of intracellular pH , 2010, Nature Reviews Molecular Cell Biology.

[191]  M. Flajnik,et al.  Origin and evolution of the adaptive immune system: genetic events and selective pressures , 2010, Nature Reviews Genetics.

[192]  V. Hachinski,et al.  Changing perspectives regarding late-life dementia , 2009, Nature Reviews Neurology.

[193]  Matthew J. Craig,et al.  CCL2 and Interleukin-6 Promote Survival of Human CD11b+ Peripheral Blood Mononuclear Cells and Induce M2-type Macrophage Polarization* , 2009, The Journal of Biological Chemistry.

[194]  J. Pinkston,et al.  Stroke and dementia , 2009, Neurological research.

[195]  J. Bazarian,et al.  Validation of serum markers for blood-brain barrier disruption in traumatic brain injury. , 2009, Journal of neurotrauma.

[196]  C. Colton.  Heterogeneity of Microglial Activation in the Innate Immune Response in the Brain , 2009, Journal of Neuroimmune Pharmacology.

[197]  M. Dichgans,et al.  CADASIL , 2009, The Lancet Neurology.

[198]  L. Walker,et al.  Alzheimer's disease and blood–brain barrier function—Why have anti-β-amyloid therapies failed to prevent dementia progression? , 2009, Neuroscience & Biobehavioral Reviews.

[199]  Stephen T. C. Wong,et al.  Bioluminescence imaging reveals inhibition of tumor cell proliferation by Alzheimer's amyloid β protein , 2009, Cancer Cell International.

[200]  A. Michelucci,et al.  Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: Effects of oligomeric and fibrillar amyloid-β , 2009, Journal of Neuroimmunology.

[201]  W. Schmidt,et al.  Development of AFFITOPE vaccines for Alzheimer’s disease (AD) — From concept to clinical testing , 2009 .

[202]  N. Zilka,et al.  Human misfolded truncated tau protein promotes activation of microglia and leukocyte infiltration in the transgenic rat model of tauopathy , 2009, Journal of Neuroimmunology.

[203]  C. Alberini,et al.  Amyloid beta mediates memory formation. , 2009, Learning & memory.

[204]  Keith A. Johnson,et al.  Cortical Hubs Revealed by Intrinsic Functional Connectivity: Mapping, Assessment of Stability, and Relation to Alzheimer's Disease , 2009, The Journal of Neuroscience.

[205]  J. Ryu,et al.  A leaky blood–brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer’s disease brain , 2008, Journal of cellular and molecular medicine.

[206]  D. Ruano,et al.  Inflammatory Response in the Hippocampus of PS1M146L/APP751SL Mouse Model of Alzheimer's Disease: Age-Dependent Switch in the Microglial Phenotype from Alternative to Classic , 2008, The Journal of Neuroscience.

[207]  Karin E. Sandoval,et al.  Blood-brain barrier tight junction permeability and ischemic stroke , 2008, Neurobiology of Disease.

[208]  J. Provias,et al.  Evidence for altered LRP/RAGE expression in Alzheimer lesion pathogenesis. , 2008, Current Alzheimer research.

[209]  V. Vasilevko,et al.  Mannan-Abeta28 conjugate prevents Abeta-plaque deposition, but increases microhemorrhages in the brains of vaccinated Tg2576 (APPsw) mice , 2008, Journal of Neuroinflammation.

[210]  J. Schmeidler,et al.  Better memory functioning associated with higher total and low-density lipoprotein cholesterol levels in very elderly subjects without the apolipoprotein e4 allele. , 2008, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[211]  J. Morrison,et al.  Stereologic estimates of total spinophilin-immunoreactive spine number in area 9 and the CA1 field: Relationship with the progression of Alzheimer's disease , 2008, Neurobiology of Aging.

[212]  David L. Brody,et al.  Amyloid-β Dynamics Correlate with Neurological Status in the Injured Human Brain , 2008, Science.

[213]  M. Spitznagel,et al.  Increased S100β Is Associated with Reduced Cognitive Function in Healthy Older Adults , 2008, Neuropsychobiology.

[214]  D. Westaway,et al.  Microglial activation in brain lesions with tau deposits: Comparison of human tauopathies and tau transgenic mice TgTauP301L , 2008, Brain Research.

[215]  George Perry,et al.  Physiological regulation of tau phosphorylation during hibernation , 2008, Journal of neurochemistry.

[216]  C. Henríquez-Roldán,et al.  Long-term Air Pollution Exposure Is Associated with Neuroinflammation, an Altered Innate Immune Response, Disruption of the Blood-Brain Barrier, Ultrafine Particulate Deposition, and Accumulation of Amyloid β-42 and α-Synuclein in Children and Young Adults , 2008, Toxicologic pathology.

[217]  B. Zlokovic.  The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders , 2008, Neuron.

[218]  David A. Bennett,et al.  Mixed brain pathologies account for most dementia cases in community-dwelling older persons , 2007, Neurology.

[219]  Patrick R Hof,et al.  Changes in the structural complexity of the aged brain , 2007, Aging cell.

[220]  D. Holtzman,et al.  Transport Pathways for Clearance of Human Alzheimer's Amyloid β-Peptide and Apolipoproteins E and J in the Mouse Central Nervous System , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[221]  T. Hortobágyi,et al.  Traumatic axonal damage in the brain can be detected using β‐APP immunohistochemistry within 35 min after head injury to human adults , 2007, Neuropathology and applied neurobiology.

[222]  Jim Mintz,et al.  Human brain myelination and amyloid beta deposition in Alzheimer’s disease , 2007, Alzheimer's & Dementia.

[223]  C. Verney,et al.  Distribution and differentiation of microglia in the human encephalon during the first two trimesters of gestation , 2006, The Journal of comparative neurology.

[224]  Jonathan Stone,et al.  Microvascular pathology in the aging human brain: Evidence that senile plaques are sites of microhaemorrhages , 2006, Neurobiology of Aging.

[225]  C. Peers,et al.  Physiological roles for amyloid β peptides , 2006 .

[226]  A. Schousboe,et al.  The glutamate/GABA‐glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer , 2006, Journal of neurochemistry.

[227]  Miles C. Miller,et al.  RAGE, LRP-1, and amyloid-beta protein in Alzheimer’s disease , 2006, Acta Neuropathologica.

[228]  E. Hansson,et al.  Astrocyte–endothelial interactions at the blood–brain barrier , 2006, Nature Reviews Neuroscience.

[229]  J. Koenigsknecht-Talboo,et al.  Microglial Phagocytosis Induced by Fibrillar β-Amyloid and IgGs Are Differentially Regulated by Proinflammatory Cytokines , 2005, The Journal of Neuroscience.

[230]  John Hardy,et al.  Dense-core plaques in Tg2576 and PSAPP mouse models of Alzheimer's disease are centered on vessel walls. , 2005, The American journal of pathology.

[231]  Tan Xiao-mei,et al.  CADASIL , 2005 .

[232]  N. Cook,et al.  Migraine, headache, and the risk of stroke in women , 2005, Neurology.

[233]  P. Mazzone,et al.  S100β as a predictor of brain metastases , 2005 .

[234]  Joseph A. Helpern,et al.  Histological Co-Localization of Iron in Aß Plaques of PS/APP Transgenic Mice , 2005, Neurochemical Research.

[235]  S. Robinson,et al.  The Amyloid Paradox: Amyloid‐β‐Metal Complexes can be Neurotoxic and Neuroprotective , 2004, Brain pathology.

[236]  J. Morrison,et al.  The aging brain: morphomolecular senescence of cortical circuits , 2004, Trends in Neurosciences.

[237]  G. Li,et al.  Nanometer size diesel exhaust particles are selectively toxic to dopaminergic neurons: the role of microglia, phagocytosis, and NADPH oxidase , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[238]  C. Iadecola.  Neurovascular regulation in the normal brain and in Alzheimer's disease , 2004, Nature Reviews Neuroscience.

[239]  K. Jellinger,et al.  Amyloid β peptide 1–42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology , 2004, Acta Neuropathologica.

[240]  J Shi,et al.  Relationships between arteriosclerosis, cerebral amyloid angiopathy and myelin loss from cerebral cortical white matter in Alzheimer's disease , 2004, Neuropathology and applied neurobiology.

[241]  D. Mann,et al.  Negative association between amyloid plaques and cerebral amyloid angiopathy in Alzheimer's disease , 2003, Neuroscience Letters.

[242]  Matthew A. Zapala,et al.  Elevated gene expression levels distinguish human from non-human primate brains , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[243]  G. Perry,et al.  Cerebrovascular requirement for sealant, anti-coagulant and remodeling molecules that allow for the maintenance of vascular integrity and blood supply , 2003, Brain Research Reviews.

[244]  J. Morrison,et al.  Progressive degeneration of nonphosphorylated neurofilament protein‐enriched pyramidal neurons predicts cognitive impairment in Alzheimer's disease: Stereologic analysis of prefrontal cortex area 9 , 2003, The Journal of comparative neurology.

[245]  Wolfgang Härtig,et al.  Reversible Paired Helical Filament-Like Phosphorylation of Tau Is an Adaptive Process Associated with Neuronal Plasticity in Hibernating Animals , 2003, The Journal of Neuroscience.

[246]  G. Silverberg,et al.  Alzheimer's disease, normal‐pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis , 2003, The Lancet Neurology.

[247]  B. Dubois,et al.  Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization , 2003, Neurology.

[248]  C. Peers,et al.  The Production of Amyloid β Peptide Is a Critical Requirement for the Viability of Central Neurons , 2003, The Journal of Neuroscience.

[249]  A. Kanner,et al.  Serum S100β , 2003, Cancer.

[250]  Joseph F. Clark,et al.  Heme and Iron Metabolism: Role in Cerebral Hemorrhage , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[251]  J. Morrison,et al.  Stereologic analysis of neurofibrillary tangle formation in prefrontal cortex area 9 in aging and Alzheimer’s disease , 2003, Neuroscience.

[252]  S. Barger,et al.  Interleukin-1 Mediates Pathological Effects of Microglia on Tau Phosphorylation and on Synaptophysin Synthesis in Cortical Neurons through a p38-MAPK Pathway , 2003, The Journal of Neuroscience.

[253]  Mark A. Smith,et al.  Cerebral Hemorrhage and Amyloid-β , 2003, Science.

[254]  R. Regan,et al.  Delayed treatment of hemoglobin neurotoxicity. , 2003, Journal of neurotrauma.

[255]  G. Perry,et al.  Amyloid‐β: A vascular sealant that protects against hemorrhage? , 2002 .

[256]  S. Robinson,et al.  Aβ as a bioflocculant: implications for the amyloid hypothesis of Alzheimer’s disease , 2002, Neurobiology of Aging.

[257]  P. Greengard,et al.  Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. , 2002, The American journal of pathology.

[258]  H. Chui,et al.  Subcortical ischaemic vascular dementia , 2002, The Lancet Neurology.

[259]  G. Bodega,et al.  Glutamine synthetase in brain: effect of ammonia , 2002, Neurochemistry International.

[260]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[261]  J. Morrison,et al.  Stereologic assessment of the total cortical volume occupied by amyloid deposits and its relationship with cognitive status in aging and Alzheimer’s disease , 2002, Neuroscience.

[262]  K. Jellinger,et al.  Alzheimer disease and cerebrovascular pathology: an update , 2002, Journal of Neural Transmission.

[263]  G. Šimić,et al.  nNOS Expression in Reactive Astrocytes Correlates with Increased Cell Death Related DNA Damage in the Hippocampus and Entorhinal Cortex in Alzheimer's Disease , 2000, Experimental Neurology.

[264]  A. Kluger,et al.  Alzheimer's disease comorbidity in normal pressure hydrocephalus: prevalence and shunt response , 2000, Journal of neurology, neurosurgery, and psychiatry.

[265]  M. Rossor,et al.  Hereditary Vascular Dementia Linked to Notch 3 Mutations: CADASIL in British Families , 2000, Annals of the New York Academy of Sciences.

[266]  S. Savolainen,et al.  Prevalence of Alzheimer's Disease in Patients Investigated for Presumed Normal Pressure Hydrocephalus: A Clinical and Neuropathological Study , 1999, Acta Neurochirurgica.

[267]  G. Šimić,et al.  Cytoskeletal changes as an alternative view on pathogenesis of Alzheimer's disease , 1998 .

[268]  J. Morrison,et al.  Life and death of neurons in the aging brain. , 1997, Science.

[269]  D. Graham,et al.  Is β-APP a marker of axonal damage in short-surviving head injury? , 1996, Acta Neuropathologica.

[270]  L. Thal,et al.  Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease , 1996, Neurology.

[271]  H. Wiśniewski,et al.  Secretion and accumulation of Alzheimer's β-protein by cultured vascular smooth muscle cells from old and young dogs , 1995, Brain Research.

[272]  W. E. Nostrand.  Zinc (II) selectively enhances the inhibition of coagulation factor XIa by protease nexin-2/amyloid β-Protein precursor , 1995 .

[273]  C. Tzourio,et al.  Case-control study of migraine and risk of ischaemic stroke in young women , 1995, BMJ.

[274]  J. Morrison,et al.  Neurofilament protein defines regional patterns of cortical organization in the macaque monkey visual system: A quantitative immunohistochemical analysis , 1995, The Journal of comparative neurology.

[275]  S. Gentleman,et al.  Distribution of β‐amyloid protein in the brain following severe head injury , 1995 .

[276]  L Carlin,et al.  Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease. , 1995, Archives of neurology.

[277]  C. Masters,et al.  Rapid induction of Alzheimer A beta amyloid formation by zinc. , 1994, Science.

[278]  L. Murray,et al.  Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[279]  P. Lansbury,et al.  The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. , 1993, Biochemistry.

[280]  J. Morrison,et al.  Evidence for early vulnerability of the medial and inferior aspects of the temporal lobe in an 82-year-old patient with preclinical signs of dementia. Regional and laminar distribution of neurofibrillary tangles and senile plaques. , 1992, Archives of neurology.

[281]  J. Teitel,et al.  Characterization of the Original Christmas Disease Mutation (Cysteine 206 → Serine): From Clinical Recognition to Molecular Pathogenesis , 1992, Thrombosis and Haemostasis.

[282]  J. Vonsattel,et al.  Cerebral amyloid angiopathy without and with cerebral hemorrhages: A comparative histological study , 1991, Annals of neurology.

[283]  R. Kalaria,et al.  The relationship of amyloid plaques to cerebral capillaries in Alzheimer's disease. , 1990, The American journal of pathology.

[284]  Kevin Cox,et al.  Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex , 1990, The Journal of comparative neurology.

[285]  J. Morrison,et al.  Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: II. Primary and secondary visual cortex , 1990, The Journal of comparative neurology.

[286]  I. Lieberburg,et al.  Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. , 1990, Science.

[287]  J. Hardy,et al.  Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch). , 1990, Science.

[288]  Carl W. Cotman,et al.  Protease nexin-II, a potent anti-chymotrypsin, shows identity to amyloid β-protein precursor , 1989, Nature.

[289]  C. Patlak,et al.  Efflux of radiolabeled polyethylene glycols and albumin from rat brain. , 1981, The American journal of physiology.

[290]  K. Stowman.  World health statistics. , 1949, The Milbank Memorial Fund quarterly.

[291]  M. Kleiber.  Body size and metabolic rate. , 1947, Physiological reviews.